While Ozempic is effective at treating type 2 diabetes and supporting weight loss, it can also come with side effects.

Strong efficacy and cardiovascular benefits should allow Novo to continue growing sales of GLP-1 therapies in diabetes. Ozempic and Rybelsus helped Novo gain share over Eli Lilly's once-weekly ...